Medical practice; ensure that stem cell therapies are used to advance medical treatments and improve patient outcomes in an ethical manner that does not involve stem cells derived from aborted fetuses

Summary

The bill allows physicians, physician assistants, and nurse practitioners to perform stem cell treatments that are not yet FDA‑approved, as long as the cells come from sources like umbilical cords and not from aborted fetuses. Patients must sign a consent form and receive a clear advertising notice about the therapy’s status. Facilities providing the cells must be FDA‑registered or accredited by specified organizations.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share